Vaccine T-cells may hold robust defensive line against Omicron variant: study

The highly mutated coronavirus variant Omicron might be able to evade the body’s first line of immune defence but is unlikely to make it through the second – T-cells, according to the results of a computational study.In a peer-reviewed article published in the journal Viruses on Sunday, researchers in Hong Kong and Australia said T-cell responses induced by vaccines, boosters and previous infections could help protect against severe illness and hospitalisation from Omicron.But the number of…

Read the original article at South China Morning Post